KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other Working Capital Changes: 2009-2025

Historic Other Working Capital Changes for Neogenomics (NEO) over the last 17 years, with Sep 2025 value amounting to $514,000.

  • Neogenomics' Other Working Capital Changes rose 152.50% to $514,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 311.43%. This contributed to the annual value of $6.8 million for FY2024, which is 189.61% up from last year.
  • As of Q3 2025, Neogenomics' Other Working Capital Changes stood at $514,000, which was up 126.10% from -$2.0 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Other Working Capital Changes ranged from a high of $11.1 million in Q4 2024 and a low of -$19.7 million during Q4 2021.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$1.6 million (2023), whereas its average is $78,000.
  • As far as peak fluctuations go, Neogenomics' Other Working Capital Changes surged by 809.85% in 2021, and later plummeted by 456.68% in 2022.
  • Quarterly analysis of 5 years shows Neogenomics' Other Working Capital Changes stood at -$19.7 million in 2021, then surged by 92.52% to -$1.5 million in 2022, then fell by 19.10% to -$1.8 million in 2023, then soared by 734.59% to $11.1 million in 2024, then soared by 152.50% to $514,000 in 2025.
  • Its Other Working Capital Changes was $514,000 in Q3 2025, compared to -$2.0 million in Q2 2025 and $3.1 million in Q1 2025.